Glial fibrillary acidic protein as a biomarker for periventricular white matter injury

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 1, 2013, Pages 27.e1-27.e7

  Stewart, Amanda ^b   Tekes, Aylin ^a,b   Huisman, Thierry A G M ^a,b   Jennings, Jacky M ^b,c   Allen, Marilee C ^a   Northington, Frances J ^a   Everett, Allen D ^a   Graham, Ernest M ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cerebral palsy; Glial fibrillary acidic protein; Periventricular white matter injury

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; STEROID;

ARTICLE; CASE CONTROL STUDY; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; GESTATIONAL AGE; HUMAN; NEWBORN; NEWBORN INTENSIVE CARE; PERIVENTRICULAR WHITE MATTER INJURY; PREECLAMPSIA; PRIORITY JOURNAL; STEROID THERAPY; VERY LOW BIRTH WEIGHT; WHITE MATTER INJURY;

EID: 84880131957     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.02.049     Document Type: Article

References (27)

1. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001;50:553-62. (Pubitemid 33009976)
2. Leviton A, Paneth N. White matter damage in preterm newborns: An epidemiologic perspective. Early Hum Dev 1990;24:1-22. (Pubitemid 20344890)
3. Milligan DW. Outcomes of children born very preterm in Europe. Arch Dis Child Fetal Neonatal Ed 2010;95:F234-40.
4. Wunderlich MT, Wallesch CW, Goertler M. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol 2006;13:1118-23. (Pubitemid 44434318)
5. Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62:1303-10. (Pubitemid 38526041)
6. Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T. Glial fibrillary acidic protein is highly correlated with brain injury. J Trauma 2008;65:778-82; discussion 782-4.
7. Kaneko T, Kasaoka S, Miyauchi T, et al. Serum glial fibrillary acidic protein as a predictive biomarker of neurological outcome after cardiac arrest. Resuscitation 2009;80:790-4.
8. Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 2012;78:1428-33.
9. Bembea MM, Savage WJ, Strouse JJ, et al. Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation. Pediatr Crit Care Med 2011;12:572-9.
10. Ennen CS, Huisman TA, Savage WJ, et al. Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am J Obstet Gynecol 2011;205:251.e1-7.
11. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34. (Pubitemid 8293290)
12. Allen MC, Aucott S, Cristofalo EA, Alexander GR, Donohue PK. Extrauterine neuromaturation of low risk preterm infants. Pediatr Res 2009;65:542-7.
13. Allen MC, Alexander GR. Using motor milestones as a multistep process to screen preterm infants for cerebral palsy. Dev Med Child Neurol 1997;39:12-6. (Pubitemid 27010751)
14. Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: A sonographic weight standard. Radiology 1991;181:129-33.
15. Volpe JJ. Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009;8: 110-24.
16. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med 2006;355:685-94.
17. Baud O, Foix-L'Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-6. (Pubitemid 29480657)
18. Wilson-Costello D. Risk factors for neurologic impairment among very low-birthweight infants. Semin Pediatr Neurol 2001;8: 120-6. (Pubitemid 32619725)
19. Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulfate given for neuroprotection before preterm birth: A randomized controlled trial. JAMA 2003;290: 2669-76. (Pubitemid 37475594)
20. Rouse DJ, Hirtz DG, Thom E, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008;359:895-905.
21. Marret S, Marpeau L, Follet-Bouhamed C, et al. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with twoyear neurological outcome: Results of the prospective PREMAG trial. Gynecol Obstet Fertil 2008;36:278-88. (Pubitemid 351418284)
22. Liu W, Shen Y, Plane JM, Pleasure DE, Deng W. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia. Exp Neurol 2011;230:227-39.
23. Titomanlio L, Kavelaars A, Dalous J, et al. Stem cell therapy for neonatal brain injury: Perspectives and challenges. Ann Neurol 2011;70:698-712.
24. Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008;93: F153-61. (Pubitemid 352038509)
25. Gilmore MM, Stone BS, Shepard JA, Czosnyka M, Easley RB, Brady KM. Relationship between cerebrovascular dysautoregulation and arterial blood pressure in the premature infant. J Perinatol 2011;31:722-9.
26. Chau V, Poskitt KJ, McFadden DE, et al. Effect of chorioamnionitis on brain development and injury in premature newborns. Ann Neurol 2009;66:155-64.
27. Silveira RC, Procianoy RS, Dill JC, da Costa CS. Periventricular leukomalacia in very low birth weight preterm neonates with high risk for neonatal sepsis. J Pediatr (Rio J) 2008;84:211-6. (Pubitemid 351840286)